Skip to main content
Liver Cancer logoLink to Liver Cancer
. 2025 Oct 8;14(6):837. doi: 10.1159/000548213

Erratum

PMCID: PMC12530802  PMID: 41112170

In the article “Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study” [Liver Cancer. 2024;13(4):426–37; https://doi.org/10.1159/000535943], by Kim et al., there was a typographical error in both the Abstract and under the heading “Definition of SLD Subtypes.”

On page 426 in the left column, the third sentence originally read: “Steatotic liver disease (SLD) was defined as a fatty liver index ≥60.” It should read: “Steatotic liver disease (SLD) was defined as a fatty liver index ≥30.”

On page 428 in the left column, under the subheading “Definitions of SLD subtypes,” the first sentence originally read: “Participants having a fatty liver index (FLI) of ≥60 were considered to have SLD.” It should read: “Participants having a fatty liver index (FLI) of ≥30 were considered to have SLD.”


Articles from Liver Cancer are provided here courtesy of Karger Publishers

RESOURCES